Isolation and characterization of antibody fragments selective for toxic oligomeric tau

Huilai Tian, Eliot Davidowitz, Patricia Lopez, Ping He, Philip Schulz, James Moe, Michael Sierks

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Oligomeric tau species are important in the onset and progression of Alzheimer's disease (AD), as they are neurotoxic and can propagate tau-tangle pathology. Therefore, reagents that selectively recognize different key morphologies of tau are needed to help define the role of tau in AD and related diseases. We utilized a biopanning protocol that combines the binding diversity of phage-displayed antibody libraries with the powerful imaging capability of atomic force microscopy to isolate single-chain antibody fragments (scFvs) that selectively bind toxic oligomeric tau. We isolated 3 different antibody fragments that bind oligomeric but not monomeric or fibrillar tau. The scFvs differentiate brain tissue homogenates of both 3×TG and tau-AD mice from wild-type mice, detecting oligomeric tau at much earlier ages than when neurofibrillary tangles are typically detected. The scFvs also distinguish human postmortem AD brain tissue from cognitively normal postmortem human brain tissue, demonstrating the potential of this approach for developing biomarkers for early detection and progression of AD.

Original languageEnglish (US)
Pages (from-to)1342-1355
Number of pages14
JournalNeurobiology of Aging
Volume36
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Immunoglobulin Fragments
Poisons
Alzheimer Disease
Brain
Single-Chain Antibodies
Neurofibrillary Tangles
Atomic Force Microscopy
Bacteriophages
Biomarkers
Pathology
Antibodies

Keywords

  • Alzheimer's disease
  • Antibody fragments
  • Biomarker
  • Brain tissue
  • Immunotherapy
  • Oligomeric tau
  • Phage display
  • ScFv
  • Toxic tau aggregates

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Isolation and characterization of antibody fragments selective for toxic oligomeric tau. / Tian, Huilai; Davidowitz, Eliot; Lopez, Patricia; He, Ping; Schulz, Philip; Moe, James; Sierks, Michael.

In: Neurobiology of Aging, Vol. 36, No. 3, 01.03.2015, p. 1342-1355.

Research output: Contribution to journalArticle

Tian, Huilai ; Davidowitz, Eliot ; Lopez, Patricia ; He, Ping ; Schulz, Philip ; Moe, James ; Sierks, Michael. / Isolation and characterization of antibody fragments selective for toxic oligomeric tau. In: Neurobiology of Aging. 2015 ; Vol. 36, No. 3. pp. 1342-1355.
@article{aff337a38928476c83270ff2db9012a4,
title = "Isolation and characterization of antibody fragments selective for toxic oligomeric tau",
abstract = "Oligomeric tau species are important in the onset and progression of Alzheimer's disease (AD), as they are neurotoxic and can propagate tau-tangle pathology. Therefore, reagents that selectively recognize different key morphologies of tau are needed to help define the role of tau in AD and related diseases. We utilized a biopanning protocol that combines the binding diversity of phage-displayed antibody libraries with the powerful imaging capability of atomic force microscopy to isolate single-chain antibody fragments (scFvs) that selectively bind toxic oligomeric tau. We isolated 3 different antibody fragments that bind oligomeric but not monomeric or fibrillar tau. The scFvs differentiate brain tissue homogenates of both 3×TG and tau-AD mice from wild-type mice, detecting oligomeric tau at much earlier ages than when neurofibrillary tangles are typically detected. The scFvs also distinguish human postmortem AD brain tissue from cognitively normal postmortem human brain tissue, demonstrating the potential of this approach for developing biomarkers for early detection and progression of AD.",
keywords = "Alzheimer's disease, Antibody fragments, Biomarker, Brain tissue, Immunotherapy, Oligomeric tau, Phage display, ScFv, Toxic tau aggregates",
author = "Huilai Tian and Eliot Davidowitz and Patricia Lopez and Ping He and Philip Schulz and James Moe and Michael Sierks",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.neurobiolaging.2014.12.002",
language = "English (US)",
volume = "36",
pages = "1342--1355",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Isolation and characterization of antibody fragments selective for toxic oligomeric tau

AU - Tian, Huilai

AU - Davidowitz, Eliot

AU - Lopez, Patricia

AU - He, Ping

AU - Schulz, Philip

AU - Moe, James

AU - Sierks, Michael

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Oligomeric tau species are important in the onset and progression of Alzheimer's disease (AD), as they are neurotoxic and can propagate tau-tangle pathology. Therefore, reagents that selectively recognize different key morphologies of tau are needed to help define the role of tau in AD and related diseases. We utilized a biopanning protocol that combines the binding diversity of phage-displayed antibody libraries with the powerful imaging capability of atomic force microscopy to isolate single-chain antibody fragments (scFvs) that selectively bind toxic oligomeric tau. We isolated 3 different antibody fragments that bind oligomeric but not monomeric or fibrillar tau. The scFvs differentiate brain tissue homogenates of both 3×TG and tau-AD mice from wild-type mice, detecting oligomeric tau at much earlier ages than when neurofibrillary tangles are typically detected. The scFvs also distinguish human postmortem AD brain tissue from cognitively normal postmortem human brain tissue, demonstrating the potential of this approach for developing biomarkers for early detection and progression of AD.

AB - Oligomeric tau species are important in the onset and progression of Alzheimer's disease (AD), as they are neurotoxic and can propagate tau-tangle pathology. Therefore, reagents that selectively recognize different key morphologies of tau are needed to help define the role of tau in AD and related diseases. We utilized a biopanning protocol that combines the binding diversity of phage-displayed antibody libraries with the powerful imaging capability of atomic force microscopy to isolate single-chain antibody fragments (scFvs) that selectively bind toxic oligomeric tau. We isolated 3 different antibody fragments that bind oligomeric but not monomeric or fibrillar tau. The scFvs differentiate brain tissue homogenates of both 3×TG and tau-AD mice from wild-type mice, detecting oligomeric tau at much earlier ages than when neurofibrillary tangles are typically detected. The scFvs also distinguish human postmortem AD brain tissue from cognitively normal postmortem human brain tissue, demonstrating the potential of this approach for developing biomarkers for early detection and progression of AD.

KW - Alzheimer's disease

KW - Antibody fragments

KW - Biomarker

KW - Brain tissue

KW - Immunotherapy

KW - Oligomeric tau

KW - Phage display

KW - ScFv

KW - Toxic tau aggregates

UR - http://www.scopus.com/inward/record.url?scp=84923627974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923627974&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2014.12.002

DO - 10.1016/j.neurobiolaging.2014.12.002

M3 - Article

C2 - 25616912

AN - SCOPUS:84923627974

VL - 36

SP - 1342

EP - 1355

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 3

ER -